rs189243324
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001145809.2(MYH14):c.1944C>T(p.Asp648=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,576,590 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001145809.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.1944C>T | p.Asp648= | splice_region_variant, synonymous_variant | 16/43 | ENST00000642316.2 | NP_001139281.1 | |
MYH14 | NM_001077186.2 | c.1944C>T | p.Asp648= | splice_region_variant, synonymous_variant | 16/42 | NP_001070654.1 | ||
MYH14 | NM_024729.4 | c.1920C>T | p.Asp640= | splice_region_variant, synonymous_variant | 15/41 | NP_079005.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH14 | ENST00000642316.2 | c.1944C>T | p.Asp648= | splice_region_variant, synonymous_variant | 16/43 | NM_001145809.2 | ENSP00000493594 |
Frequencies
GnomAD3 genomes AF: 0.00112 AC: 170AN: 152184Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000329 AC: 63AN: 191498Hom.: 1 AF XY: 0.000291 AC XY: 30AN XY: 102938
GnomAD4 exome AF: 0.000189 AC: 269AN: 1424288Hom.: 1 Cov.: 29 AF XY: 0.000177 AC XY: 125AN XY: 705492
GnomAD4 genome AF: 0.00112 AC: 171AN: 152302Hom.: 1 Cov.: 32 AF XY: 0.00109 AC XY: 81AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 07, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 05, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2023 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | p.Asp648Asp in exon 16 of MYH14: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, and has been identi fied in 0.4% (14/3596) of African American chromosomes from a broad population b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 04, 2017 | - - |
MYH14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 20, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at